Snail egg article retracted for fishing for material from six other papers

APJTB_ak1The first author of a review article on extracting pharmacological compounds from marine organisms, published in the Asian Pacific Journal of Tropical Biomedicine, has retracted it due to plagiarism.

There were also some authorship issues, according to the retraction notice for the paper, which absolves the last author, based at Pondicherry University in India, from responsibility:

This article has been retracted at the request of the Editor-in-Chief and the First Author. Both the first author and the journal’s editor confirmed that Dr. A Yogamoorthi is not responsible for the plagiarism since his/her name was added without consent.

There is one other author, R. Siva Sankar, also based at Pondicherry. Somewhere along the way, according to the retraction note, the paper scooped up wording from six papers previously published by researchers in Australia. Here’s more from the retraction note for “Antimicrobial secondary metabolites from marine gastropod egg capsules and egg masses”: Continue reading Snail egg article retracted for fishing for material from six other papers

Chinese medical case study erased after guardian consent withdrawn

JMCRThe editor of the Journal of Medical Case Reports, a BioMed Central title, has retracted and removed a case study of a novel surgical treatment after the patient’s legal guardian withdrew consent post-publication.

The paper, “Novel two-stage surgical treatment for Cantrell syndrome complicated by severe pulmonary hypertension: a case report,” describes the treatment of a six-month-old Han Chinese girl suffering from a rare combination of birth defects called Cantrell syndrome, complicated by pulmonary hypertension.

The original article, published in March 2014, has been removed from the journal’s website, though the abstract can be read on PubMed. It is unclear whether the authors, the child’s guardian, or some other party informed the editor of the withdrawal of consent.

The brief notice offers few details:

Continue reading Chinese medical case study erased after guardian consent withdrawn

Former Florida ob-gyn prof notches eighth retraction

University of Florida
University of Florida

Nasser Chegini, the former University of Florida professor currently under investigation by the Office of Research Integrity (ORI), has now had eight papers retracted.

The eighth paper, in the journal Reproductive Biology and Endocrinology, is about the effect of a compound used during fertility treatments on Smads, signaling molecules that carry messages from TGF-beta receptors to the nucleus. It’s being retracted disappeared due to the discovery of data that “have been fabricated or falsified by the last author” — namely, Chegini.

Here’s more from the notice for “Gonadotropin releasing hormone analogue (GnRHa) alters the expression and activation of Smad in human endometrial epithelial and stromal cells:” Continue reading Former Florida ob-gyn prof notches eighth retraction

Retraction Watch is hiring!

anniversarySince becoming our intern in June of last year, and then our first-ever staff writer in October, Cat Ferguson has written more than 200 posts, breaking news left and right. But as we noted on Twitter the other day with not a small degree of sadness, Cat has left Retraction Watch for a great gig at BuzzFeed.

That means we’re hiring.

The job is definitely fast-paced. Continue reading Retraction Watch is hiring!

Trove of VA reports reveals research misconduct, medical malpractice

va logoLast week, the Veteran Affairs Office of Inspector General released eight years of reports investigating allegations of nefarious behavior at VA hospitals and institutions around the country, ranging from mistreating a patient in Florida, misspending grant money in New York, and conducting unauthorized research in Iowa.

In one report, Continue reading Trove of VA reports reveals research misconduct, medical malpractice

Weekend reads: Faith-based peer review; lab bloopers; post-publication peer review etiquette

The week at Retraction Watch featured a lawsuit over the authorship of a paper, and a look at when exactly a study should be retracted. Here’s what was happening elsewhere:

Continue reading Weekend reads: Faith-based peer review; lab bloopers; post-publication peer review etiquette

When should a paper be retracted? A tale from the obesity literature

obesity factsIn our line of work, we see it all — mega-corrections that don’t quite rise to the level of retraction, letters to the editor that point out seemingly fatal flaws in papers that remain untouched, and studies retracted for what seem like minor reasons. It can make you wonder what makes a paper worthy of a retraction. A recent case in an obesity journal may not provide a definitive answer, but it gives us a lot to chew on.

Here’s the story: In September 2013, Rosely Sichieri and a colleague from the State University of Rio de Janeiro submitted an article to Obesity Facts, “Unbalanced Baseline in School-Based Interventions to Prevent Obesity: Adjustment Can Lead to Bias?” The article examined statistical issues in randomized controlled trials of school-based weight loss programs. Peer reviewers said the paper needed major revisions before it could be accepted; the authors revised the paper enough in a second draft, submitted in November 2013, that the original reviewers accepted it. The paper was published in June 2014.

Then, in September 2014, a group of authors including David Allison of the University of Alabama, Birmingham, and colleagues from Clemson, Thomas Jefferson, and the University of Minnesota, wrote a critical letter that was published in the journal in April. The letter, according to a just-published editorial: Continue reading When should a paper be retracted? A tale from the obesity literature

Urology researcher in Iran up to six retractions

safarinejadA urologist in Iran has lost three papers in BJU International, bringing his retraction count to a half-dozen.

In December 2013, we reported on three retractions by Mohammad Reza Safarinejad. None of those notices, about papers related to incontinence and erectile dysfunction, made the reasons for retraction very clear. After that post ran, Safarinejad told us that Hartmut Porst, former president of the European Society for Sexual Medicine, had raised questions about the data in a number of his papers. Porst confirmed that for us earlier this month.

All of the latest papers, about aspects of male sexual dysfunction, are being retracted due to “inappropriate” statistical analyses.

Here’s the notice for “Analysis of association between the 5-HTTLPR and STin2 polymorphisms in the serotonin-transporter gene and clinical response to a selective serotonin reuptake inhibitor (sertraline) in patients with premature ejaculation,” which has been cited 17 times, according to Thomson Scientific’s Web of Knowledge: Continue reading Urology researcher in Iran up to six retractions

Does peer review ferret out the best science? New study tries to answer

scienceGrant reviewers at the U.S. National Institutes of Health are doing a pretty good job of spotting the best proposals and ranking them appropriately, according to a new study in Science out today.

Danielle Li at Harvard and Leila Agha at Boston University found that grant proposals that earn good scores lead to research that is more cited, more published, and published in high-impact journals. These findings were upheld even when they controlled for notoriously confounding factors, such as the applicant’s institutional quality, gender, history of funding and experience, and field.

Taking all those factors into consideration, grant scores that were 1 standard deviation lower (10.17 points, in the analysis) led to research that earned 15% fewer citations and 7% fewer papers, along with 19% fewer papers in top journals.

Li tells Retraction Watch that, while some scientists may not be surprised by these findings, previous research has suggested there isn’t much of a correlation between grant scores and outcomes:

Continue reading Does peer review ferret out the best science? New study tries to answer

Use of data “without permission,” bad authors list, and hidden funding sink mol bio paper

dna cell biology 2A Chinese researcher has lost a paper after the journal discovered he published others’ research without permission and lied about the grant funding he used for the work.

Yihang Shen published a paper using his PhD research on the molecular biology of fetal rodent livers earlier this year in DNA and Cell Biology. Unfortunately, he didn’t have permission to publish the data. He also omitted the names of people who participated in the research, and listed an incorrect funding source.

The “cited grant,” according to the journal editor, was a grant awarded to Richard Finnell, a UT Austin researcher who often works with Shen’s PhD advisor at Shanghai Jiao Tong University, the well-known geneticist Fanyi Zeng.

Here’s the notice for “Characterization of Hydroxymethylation Patterns in the Promoter of b-globin Clusters in Murine Fetal Livers”: Continue reading Use of data “without permission,” bad authors list, and hidden funding sink mol bio paper